KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Revenue (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Revenue for 17 consecutive years, with $24.6 billion as the latest value for Q4 2025.

  • Quarterly Revenue rose 9.08% to $24.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94.2 billion through Dec 2025, up 6.05% year-over-year, with the annual reading at $94.2 billion for FY2025, 6.05% up from the prior year.
  • Revenue hit $24.6 billion in Q4 2025 for Johnson & Johnson, up from $24.0 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $24.6 billion in Q4 2025 to a low of $19.8 billion in Q2 2022.
  • Historically, Revenue has averaged $22.0 billion across 5 years, with a median of $22.1 billion in 2021.
  • Biggest five-year swings in Revenue: rose 27.14% in 2021 and later decreased 14.32% in 2022.
  • Year by year, Revenue stood at $23.3 billion in 2021, then fell by 14.32% to $20.0 billion in 2022, then rose by 7.0% to $21.4 billion in 2023, then rose by 5.26% to $22.5 billion in 2024, then rose by 9.08% to $24.6 billion in 2025.
  • Business Quant data shows Revenue for JNJ at $24.6 billion in Q4 2025, $24.0 billion in Q3 2025, and $23.7 billion in Q2 2025.